Mission Bio Inc

Novome Biotechnologies is a South San Francisco-based company that specializes in engineering living medicines for chronic diseases. Their innovative approach involves building cell therapies that are precise, extensible, and symbiotic with the patient, aiming to achieve long-term health. Novome's platform, GEMMs (Genetically Engineered Microbial Medicines), focuses on colonizing the gut with engineered microbes to deliver targeted therapeutic activities for sustained and effective treatments. With a strong emphasis on well-defined mechanisms of action and tunable treatment, Novome's therapies utilize highly-abundant gut microbes that are programmed with specific therapeutic functions. Their approach allows for convenient delivery through small, oral doses of a universal strain, making treatment safe, non-invasive, and tailored to specific conditions. Through their pipeline of programs, Novome aims to address a variety of diseases with clear etiology, including enteric hyperoxaluria, irritable bowel syndrome, and immuno-oncology.Generated from the website

Walking Fish Therapeutics, Inc. is a biotech company based in South San Francisco, CA, specializing in the development of cell-based therapeutics for the treatment of serious diseases, with a focus on oncology and regenerative therapies. They have created a powerful B cell platform that harnesses the production capabilities of B cells to deliver multiple potent therapeutic proteins, offering potential applications in various fields such as autoimmune diseases, infectious diseases, deficiency diseases, and cancer treatment. Co-founded and led by Lewis Rusty Williams, an experienced entrepreneur in the biotech industry, Walking Fish Therapeutics has assembled a distinguished team of experts in cell engineering, manufacturing, and clinical research, supported by renowned scientific and strategic advisors. With their deep understanding of B cell biology and critical advances in engineering technologies, Walking Fish is at the forefront of this emerging field, aiming to revolutionize the development of B cell therapies for multiple diseases.Generated from the website

Alumis provides precision medicines. They transform the lives of patients with autoimmune diseases. They bring a proven track record in precision drug development of groundbreaking therapies. They rewrite the autoimmune treatment playbook with a unique precision analytics platform to advancing their understanding of immunologic diseases. They build a pipeline of therapeutics based on genetically validated targets for application in the treatment of multiple autoimmune disease indications.